CYTOSORBENTS CORPORATION - COMMON STOCK

CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled

20 апр 2023 07:00:01 Источник Nasdaq GlobeNewswire

CytoSorbents Announces Board Chairman Al W. Kraus To Retire

19 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire

Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation

29 мар 2023 08:30:00 Источник Nasdaq GlobeNewswire

CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)

22 мар 2023 08:09:06 Источник Nasdaq GlobeNewswire

CytoSorbents Comments on Bank Exposure and Diversified Cash Position

14 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Reports Fourth Quarter and Full Year 2022 Results

09 мар 2023 16:15:00 Источник Nasdaq GlobeNewswire

New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time

07 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire